{
    "2019-09-06": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Notable ETF Inflow Detected - IHI, MDT, TMO, DHR",
                "features": {
                    "keywords": [
                        "ETF",
                        "Inflow",
                        "IHI",
                        "MDT",
                        "TMO",
                        "DHR"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Thermo Fisher, Danaher among firms competing for KKR's LGC Group - Bloomberg",
                "features": {
                    "keywords": [
                        "Thermo Fisher",
                        "Danaher",
                        "KKR",
                        "LGC Group",
                        "Bloomberg"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "life sciences"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Thermo Fisher, Danaher Among Firms Eyeing KKR's LGC",
                "features": {
                    "keywords": [
                        "Thermo Fisher",
                        "Danaher",
                        "KKR",
                        "LGC"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "life sciences"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Inside drugmakers' strategy to boost cancer medicines with 'Lazarus effect'",
                "features": {
                    "keywords": [
                        "drugmakers",
                        "cancer medicines",
                        "Lazarus effect"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "oncology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "INSIGHT-Inside drugmakers' strategy to boost cancer medicines with \"Lazarus effect\"",
                "features": {
                    "keywords": [
                        "drugmakers",
                        "cancer medicines",
                        "Lazarus effect"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "oncology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}